Nautilus Biotechnology Announces Board and Executive Changes
Ticker: NAUT · Form: 8-K · Filed: Jan 31, 2025 · CIK: 1808805
| Field | Detail |
|---|---|
| Company | Nautilus Biotechnology, INC. (NAUT) |
| Form Type | 8-K |
| Filed Date | Jan 31, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-compensation
TL;DR
Nautilus Biotech shakes up board and exec pay. Big changes coming?
AI Summary
Nautilus Biotechnology, Inc. announced on January 27, 2025, changes in its board of directors and executive compensation. Specifically, the company reported the departure of certain officers and directors, the election of new directors, and adjustments to compensatory arrangements for its key executives.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook, impacting investor confidence.
Risk Assessment
Risk Level: medium — Board and executive changes can introduce uncertainty regarding future strategy and leadership stability.
Key Numbers
- 001-39434 — SEC File Number (Identifies the company's filings with the SEC.)
- 98-1541723 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Nautilus Biotechnology, Inc. (company) — Registrant
- January 27, 2025 (date) — Date of earliest event reported
- 206-333-2001 (phone_number) — Registrant's telephone number
- Seattle, Washington (location) — Principal executive offices
- ARYA Sciences Acquisition Corp III (company) — Former company name
FAQ
Who are the specific officers or directors that have departed from Nautilus Biotechnology, Inc.?
The filing indicates the departure of 'Directors or Certain Officers' but does not name the specific individuals in the provided text.
Who are the newly elected directors?
The filing states the election of directors but does not provide their names in the provided text.
What specific changes were made to the compensatory arrangements of certain officers?
The filing mentions 'Compensatory Arrangements of Certain Officers' as an item being reported, but the details of these arrangements are not specified in the provided text.
What is the exact date of the reported changes?
The date of the earliest event reported is January 27, 2025.
What was Nautilus Biotechnology, Inc.'s former company name?
Nautilus Biotechnology, Inc.'s former company name was ARYA Sciences Acquisition Corp III.
Filing Stats: 461 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2025-01-31 17:15:22
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share NAUT The Nasdaq Stock Market
Filing Documents
- naut-20250127.htm (8-K) — 23KB
- 0001808805-25-000002.txt ( ) — 146KB
- naut-20250127.xsd (EX-101.SCH) — 2KB
- naut-20250127_lab.xml (EX-101.LAB) — 22KB
- naut-20250127_pre.xml (EX-101.PRE) — 13KB
- naut-20250127_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: January 31, 2025 NAUTILUS BIOTECHNOLOGY, INC. By: /s/ Sujal Patel Name: Sujal Patel Title: Chief Executive Officer